# Tensha Therapeutics, Inc. — Form D

Tensha Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2011-08-08. The offering totals $15.0M, of which $500K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2011-08-08
- Form: D
- Accession: 0001140361-11-040189
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $15.0M
- Amount sold: $500K
- Remaining: $14.5M
- Investors: 2
- Date of first sale: 2011-07-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-164058

## Issuer

- Name: Tensha Therapeutics, Inc.
- CIK: 0001526865
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 55 CAMBRIDGE PARKWAY, CAMBRIDGE, MA, 02142
- Phone: 617-252-4343

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| James E Bradner | Director | Cambridge, MA |
| Augustine E Lawlor | Director | Cambridge, MA |
| Douglas E Onsi | Director | Cambridge, MA |
| Douglas E Onsi | Executive Officer | Cambridge, MA |

## More

- [CIK 1526865 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1526865&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001140361-11-040189.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.